CASI
CASI Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.15
+3.08%Leverage
- Debt / equity
- -0.66x
- Net debt / equity
- -0.50x
- Debt / assets
- 0.77x
- Debt / EBITDA
- -0.46x
- Net debt / EBITDA
- -0.34x
Liquidity & coverage
- Current ratio
- 0.30x
- Quick ratio
- 0.24x
- Cash ratio
- 0.12x
- Interest coverage
- -70.90x
- EBITDA / interest
- -65.05x
- Working capital
- -$27.5M
Cash & dividend
- FCF / debt
- 0.00x
- Cash flow / debt
- 0.00x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2025